drugset / Trial / NCT01861249
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
NaSingle-groupOpen-labelTreatment
Summary
Primary Objective: To assess the long term safety and tolerability of SAR339658 Secondary Objective: To assess the long term efficacy of SAR339658
Timeline
- Start
- 2013-07
- Primary completion
- 2014-05
- Completion
- 2016-04
Outcome
Outcome not reported
Stopped (Enrollment): “Recruitment was early terminated due to slow recruitment. Not linked to any safety concern.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vatelizumab | Monoclonal antibody | — | Intravenous |